Clinical Study
Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
Table 5
The five-year survival of patients with and without poor prognostic factors.
| | Prognostic factors | 2-year survival (%) | 5-year survival (%) |
| | Stage of lung cancer | | | | Stage IA | 76.8 | 61.7 | | Stage IB | 76.8 | 44.7 | | Stage IIA | 54.0 | 37.1 | | Stage IIB | 43.0 | 43.0 | | Tumor necrosis | | | | No | 75.3 | 54.6 | | Yes | 54.1 | 37.3 | | Tumor recurrence | | | | No | 86.6 | 76.5 | | Yes | 47.1 | 23.6 | | Brain metastasis | | | | No | 73.0 | 52.3 | | Yes | 18.2 | 9.1 | | Skin metastasis | | | | No | 70.0 | 50.0 | | Yes | 0.0 | 0.0 | | Adrenal metastasis | | | | No | 67.9 | 48.3 | | Yes | 0.0 | 0.0 |
|
|
